Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

CD4 T-cell-independent antibody response reduces enterovirus 71 lethality in mice by decreasing tissue viral loads.

Wang LC, Kao CM, Ling P, Su IJ, Chang TM, Chen SH.

Clin Dev Immunol. 2012;2012:580696. doi: 10.1155/2012/580696. Epub 2012 Oct 24.

2.

Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads.

Lin YW, Chang KC, Kao CM, Chang SP, Tung YY, Chen SH.

J Virol. 2009 Jul;83(13):6477-83. doi: 10.1128/JVI.00434-09. Epub 2009 Apr 22.

3.

Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps.

Ku Z, Ye X, Huang X, Cai Y, Liu Q, Li Y, Su Z, Huang Z.

PLoS One. 2013;8(2):e57601. doi: 10.1371/journal.pone.0057601. Epub 2013 Feb 22.

4.

Enterovirus 71 infection increases expression of interferon-gamma-inducible protein 10 which protects mice by reducing viral burden in multiple tissues.

Shen FH, Tsai CC, Wang LC, Chang KC, Tung YY, Su IJ, Chen SH.

J Gen Virol. 2013 May;94(Pt 5):1019-27. doi: 10.1099/vir.0.046383-0. Epub 2013 Jan 3.

PMID:
23288420
5.

A Potent Virus-Specific Antibody-Secreting Cell Response to Acute Enterovirus 71 Infection in Children.

Huang KY, Lin JJ, Chiu CH, Yang S, Tsao KC, Huang YC, Lin TY.

J Infect Dis. 2015 Sep 1;212(5):808-17. doi: 10.1093/infdis/jiv094. Epub 2015 Feb 23.

PMID:
25712974
6.

Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice.

Chen IC, Wang SM, Yu CK, Liu CC.

Med Microbiol Immunol. 2013 Aug;202(4):259-65. doi: 10.1007/s00430-013-0289-y. Epub 2013 Feb 14.

PMID:
23408291
7.

Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.

Lin YL, Yu CI, Hu YC, Tsai TJ, Kuo YC, Chi WK, Lin AN, Chiang BL.

Vaccine. 2012 Feb 8;30(7):1305-12. doi: 10.1016/j.vaccine.2011.12.081. Epub 2011 Dec 31.

PMID:
22214888
8.

Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses.

Dodd KA, McElroy AK, Jones ME, Nichol ST, Spiropoulou CF.

J Virol. 2013 Jun;87(11):6161-71. doi: 10.1128/JVI.00337-13. Epub 2013 Mar 27.

9.
10.

Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice.

Kolpe AB, Kiener TK, Grotenbreg GM, Kwang J.

Virus Res. 2012 Sep;168(1-2):64-72. doi: 10.1016/j.virusres.2012.06.014. Epub 2012 Jun 20.

PMID:
22728446
11.

Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection.

Chang GH, Luo YJ, Wu XY, Si BY, Lin L, Zhu QY.

Virol J. 2010 May 26;7:106. doi: 10.1186/1743-422X-7-106.

12.

A dominant EV71-specific CD4+ T cell epitope is highly conserved among human enteroviruses.

Wei R, Yang C, Zeng M, Terry F, Zhu K, Yang C, Altmeyer R, Martin W, De Groot AS, Leng Q.

PLoS One. 2012;7(12):e51957. doi: 10.1371/journal.pone.0051957. Epub 2012 Dec 14. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/434cdaa5-9654-4052-b325-fef0f31d4657.

13.

Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.

Han JF, Cao RY, Deng YQ, Tian X, Jiang T, Qin ED, Qin CF.

Virol J. 2011 Mar 8;8:106. doi: 10.1186/1743-422X-8-106.

14.

Cross-reactivity of anti-EV71 IgM and neutralizing antibody in series sera of patients infected with Enterovirus 71 and Coxsackievirus A 16.

Lin Y, Wen K, Pan Y, Wang Y, Che X, Wang B.

J Immunoassay Immunochem. 2011;32(3):233-43. doi: 10.1080/15321819.2011.559297.

PMID:
21574094
15.

Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells.

Matter MS, Hilmenyuk T, Claus C, Marone R, Schürch C, Tinguely M, Terracciano L, Luther SA, Ochsenbein AF.

PLoS One. 2011;6(9):e24772. doi: 10.1371/journal.pone.0024772. Epub 2011 Sep 23.

16.

Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains.

He F, Kiener TK, Lim XF, Tan Y, Raj KV, Tang M, Chow VT, Chen Q, Kwang J.

PLoS One. 2013;8(1):e55517. doi: 10.1371/journal.pone.0055517. Epub 2013 Jan 31.

17.

Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach.

Kirk K, Poh CL, Fecondo J, Pourianfar H, Shaw J, Grollo L.

Vaccine. 2012 Nov 19;30(49):7105-10. doi: 10.1016/j.vaccine.2012.09.030. Epub 2012 Sep 26.

PMID:
23022400
18.

Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection.

Cao RY, Dong DY, Liu RJ, Han JF, Wang GC, Zhao H, Li XF, Deng YQ, Zhu SY, Wang XY, Lin F, Zhang FJ, Chen W, Qin ED, Qin CF.

PLoS One. 2013 May 20;8(5):e64024. doi: 10.1371/journal.pone.0064024. Print 2013.

19.

Early dexamethasone treatment exacerbates enterovirus 71 infection in mice.

Shen FH, Shen TJ, Chang TM, Su IJ, Chen SH.

Virology. 2014 Sep;464-465:218-27. doi: 10.1016/j.virol.2014.07.021. Epub 2014 Aug 5.

20.

Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein.

Kiener TK, Jia Q, Lim XF, He F, Meng T, Chow VT, Kwang J.

Virol J. 2012 Feb 24;9:55. doi: 10.1186/1743-422X-9-55.

Supplemental Content

Support Center